Please provide your email address to receive an email when new articles are posted on . A metallo-beta-lactam inhibitor could help fight resistance to beta-lactam antibiotics. MK-3402 was found to be ...
Crystal structure of the metallo-beta-lactamase protein 5-(pyridine-3-sulfonamido)-1,3-thiazole-4-carboxylic acid (ANT-431) (image by Simon Leiris). Researchers from the lab group of Michael Crowder, ...
Council of Scientific and Industrial Research (India) has synthesized substituted tricyclic heterocyclic compounds acting as β-lactamase IMP-1 (bacterial) and/or New Delhi metallo-β-lactamase-1 (NDM-1 ...
Michael Crowder, professor and chair of chemistry, has recently had his research article, "The Continuing Challenge of Metallo-b-Lactamase Inhibition: Mechanism Matters," accepted by Trends in ...
Let us consider the following hypothetical scenario. A 48-year-old man with a history of type 2 diabetes mellitus was recently on vacation in Calcutta, India. Three days into his stay, he was involved ...
MALVERN, Pa.--(BUSINESS WIRE)--Venatorx Pharmaceuticals, a private, pre-commercial pharmaceutical company focused on improving health outcomes for patients with difficult-to-treat drug resistant ...
Kumarasamy et al. [5] recently provided evidence that NDM-producing Enterobacteriaceae (mostly K. pneumoniae and E. coli) are widespread in the Indian subcontinent. They also found that many patients ...
After creating a huge controversy by claiming that foreign patients who were treated in India developed antibiotic resistance, authors of the superbug New Delhi metallo-B-lactamase-1 (NDM-1) bacteria ...
Though a paper on the ‘New Delhi Metallo-beta lactamase bacteria’ in the latest issue of a British medical journal has led to allegations of a ‘Western plot’ to undermine medical tourism in India, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback